Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study
Robert K. Nam(Sunnybrook Health Science Centre), Arun Seth(Sunnybrook Health Science Centre), Christopher Sherman(Sunnybrook Health Science Centre), Laurence Klotz(University of Toronto), Stephanie Bacopulos(Sunnybrook Health Science Centre), Jessica Stojcic-Bendavid(Sunnybrook Health Science Centre), Tania Benatar(Sunnybrook Health Science Centre), Steven A. Narod(Women's College Hospital), Christopher J.D. Wallis(University Health Network), Aiguo Zhang(Henan University), Linda Sugar(Sunnybrook Health Science Centre), Magda Naeim(Sunnybrook Health Science Centre), Wen‐Yi Yang(Shanghai University), Yutaka Amemiya(Sunnybrook Health Science Centre)
Cited by 36
Related Papers
The OxyS regulatory RNA represses rpoS translation and binds the Hfq (HF‐I) protein
|The EMBO Journal|1998|788
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
|JAMA Oncology|2015|618
Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline
|Journal of Clinical Oncology|2007|556